Literature DB >> 30892604

Priorities for research in multiple conditions in later life (multi-morbidity): findings from a James Lind Alliance Priority Setting Partnership.

S G Parker1,2, L Corner3, K Laing1, G Nestor4, D Craig1, J Collerton5, J Frith6, H C Roberts7, A A Sayer2,8,9, L M Allan10, L Robinson1,2, K Cowan11.   

Abstract

INTRODUCTION: multiple conditions in later life (multi-morbidity) is a major challenge for health and care systems worldwide, is of particular relevance for older people, but has not (until recently) received high priority as a topic for research. We have identified the top 10 research priorities from the perspective of older people, their carers, and health and social care professionals using the methods of a James Lind Alliance Priority Setting Partnership.
METHODS: in total, 354 participants (162 older people and carers, 192 health professionals) completed a survey and 15 older people and carers were interviewed to produce 96 'unanswered questions'. These were further refined by survey and interviews to a shortlist of 21 topics, and a mix of people aged 80+ living with three or more conditions, carers and health and social care providers to prioritised the top 10.
RESULTS: the key priorities were about the prevention of social isolation, the promotion of independence and physical and emotional well-being. In addition to these broad topics, the process also identified detailed priorities including the role of exercise therapy, the importance of falls (particularly fear of falling), the recognition and management of frailty and Comprehensive Geriatric Assessment.
CONCLUSION: these topics provide a unique perspective on research priorities on multiple conditions in later life and complement existing UK and International recommendations about the optimisation of health and social care systems to deliver essential holistic models of care and the prevention and treatment of multiple co-existing conditions.
© The Author(s) 2019. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  multimorbidity; older people; public involvement; research priorities

Mesh:

Year:  2019        PMID: 30892604     DOI: 10.1093/ageing/afz014

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  4 in total

1.  Availability and Quality of Assessment Instruments on Patient-Centredness in the Multimorbid Elderly (AQuA-PCE): a study protocol of a systematic review.

Authors:  Manuela Glattacker; Manuela Kanat; Jonas Schaefer; Edith Motschall; Laura Kivelitz; Sebastian Voigt-Radloff; Joerg Dirmaier
Journal:  BMJ Open       Date:  2020-02-05       Impact factor: 2.692

2.  Physical activity and sedentary behaviour interventions for people living with both frailty and multiple long-term conditions: a scoping review protocol.

Authors:  Hannah M L Young; Thomas Yates; Paddy C Dempsey; Louisa Y Herring; Joseph Henson; Jack Sargeant; Ffion Curtis; Harini Sathanapally; Patrick J Highton; Michelle Hadjiconstantinou; Rebecca Pritchard; Selina Lock; Sally J Singh; Melanie J Davies
Journal:  BMJ Open       Date:  2022-05-04       Impact factor: 3.006

Review 3.  Research priority setting related to older adults: a scoping review to inform the Cochrane-Campbell Global Ageing Partnership work programme.

Authors:  Victoria I Barbeau; Leen Madani; Abdulah Al Ameer; Elizabeth Tanjong Ghogomu; Deirdre Beecher; Monserrat Conde; Tracey E Howe; Sue Marcus; Richard Morley; Mona Nasser; Maureen Smith; Jo Thompson Coon; Vivian A Welch
Journal:  BMJ Open       Date:  2022-09-19       Impact factor: 3.006

4.  Benefits and harms of exercise therapy in people with multimorbidity: A systematic review and meta-analysis of randomised controlled trials.

Authors:  Alessio Bricca; Lasse K Harris; Madalina Jäger; Susan M Smith; Carsten B Juhl; Søren T Skou
Journal:  Ageing Res Rev       Date:  2020-09-05       Impact factor: 10.895

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.